Belinostat
CAS No. 866323-14-0
Belinostat ( PXD101 | PX105684 | PXD-101 | PXD 101 | PX-105684 )
产品货号. M16294 CAS No. 866323-14-0
一种有效的 HDAC 抑制剂,IC50 为 27 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥373 | 有现货 |
|
| 10MG | ¥603 | 有现货 |
|
| 25MG | ¥918 | 有现货 |
|
| 50MG | ¥1386 | 有现货 |
|
| 100MG | ¥1962 | 有现货 |
|
| 200MG | ¥3132 | 有现货 |
|
| 500MG | ¥5004 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥143 | 有现货 |
|
生物学信息
-
产品名称Belinostat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的 HDAC 抑制剂,IC50 为 27 nM。
-
产品描述A potent HDAC inhibitor with IC50 of 27 nM (HeLa cell extracts); inhibits histone deacetylase activity in cell lysates with IC50 of 9-100 nM, increases the acetylation of histone H4 and induces apoptosis in tumor cell lines; inhibits the growth of a range of human tumor cell lines in vitro (IC50=0.2-3.4 uM); shows antitumor activity in vivo with no apparent toxicity.Blood Cancer Approved.
-
体外实验Belinostat (PXD101) induces a concentration-dependent (0.2-5 μM) increase in acetylation of histone H4 in tumor cell lines. Belinostat is cytotoxic in vitro in a number of tumor cell lines with IC50s in the range 0.2-3.4 μM as determined by a clonogenic assay and induces apoptosis. Belinostat inhibits the growth of a number of human tumor cell lines in vitro with IC50s determined by a clonogenic assay in the range 0.2-3.4 μM. Belinostat (PXD101) is a potent histone deacetylase (HDAC) inhibitor, potently inhibits the enzymatic activity of purified recombinant HDAC6 (IC50 of 82 nM).
-
体内实验Treatment of nude mice bearing human ovarian and colon tumor xenografts with Belinostat (10-40 mg/kg/day i.p.) daily for 7 days causes a significant dose-dependent growth delay with no obvious signs of toxicity to the mice. Growth delay is also observed for xenografts of cisplatin-resistant ovarian tumor cells. A marked increase in acetylation of H4 is detected in blood and tumor of mice 3 h after treatment with Belinostat (PXD101). The inhibition of growth of human tumor xenografts in mice, with no apparent toxicity. Belinostat (PXD101) displays single-agent antitumor activity on human A2780 ovarian cancer s.c. xenografts which is enhanced via combination therapy with Carboplatin.
-
同义词PXD101 | PX105684 | PXD-101 | PXD 101 | PX-105684
-
通路Cell Cycle/DNA Damage
-
靶点HDAC
-
受体HDAC
-
研究领域Cancer
-
适应症Blood cancer
化学信息
-
CAS Number866323-14-0
-
分子量318.3477
-
分子式C15H14N2O4S
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(NO)/C=C/C1=CC=CC(S(=O)(NC2=CC=CC=C2)=O)=C1
-
化学全称2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Plumb JA, et al. Mol Cancer Ther. 2003 Aug;2(8):721-8.
2. Qian X, et al. Mol Cancer Ther. 2006 Aug;5(8):2086-95.
3. Buckley MT, et al. J Transl Med. 2007 Oct 12;5:49.
021-51111890
购物车()
sales@molnova.cn

